Follow-Up Care for Children Prescribed ADHD Medication (ADD): Continuation and Maintenance Phase

HEDIS® Measurement Description: Continuation and Maintenance (C&M) Phase. The percentage of members 6-12 years of age as of
the IPSD with an ambulatory prescription dispensed for ADHD medication, who remained on the medication for at least 210 days and who, in addition to the visit in the Initiation Phase, had at least two follow-up visits with a practitioner within 270 days (9 months) after the Initiation Phase ended.

Measure Identifier: HEDIS_ADD.A.CON

Please see Report Details below for more information on selected subgroups, organizations, and aggregation.

Tables

Data


HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).